- Home
- COSM vs LUMO Comparison
COSM vs LUMO Comparison
Compare COSM & LUMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- LUMO
- Stock Information
- Founded
- COSM 2009
- LUMO 2011
- Country
- COSM United States
- LUMO United States
- Employees
- COSM N/A
- LUMO N/A
- Industry
- COSM Other Pharmaceuticals
- LUMO Biotechnology: Pharmaceutical Preparations
- Sector
- COSM Health Care
- LUMO Health Care
- Exchange
- COSM Nasdaq
- LUMO Nasdaq
- Market Cap
- COSM 19.2M
- LUMO 17.7M
- IPO Year
- COSM 2013
- LUMO N/A
- Fundamental
- Price
- COSM $1.08
- LUMO $3.80
- Analyst Decision
- COSM
- LUMO Strong Buy
- Analyst Count
- COSM 0
- LUMO 2
- Target Price
- COSM N/A
- LUMO $20.50
- AVG Volume (30 Days)
- COSM 1.1M
- LUMO 172.4K
- Earning Date
- COSM 08-19-2024
- LUMO 11-05-2024
- Dividend Yield
- COSM N/A
- LUMO N/A
- EPS Growth
- COSM N/A
- LUMO N/A
- EPS
- COSM N/A
- LUMO N/A
- Revenue
- COSM $56,454,858.00
- LUMO $1,486,000.00
- Revenue This Year
- COSM $22.27
- LUMO $273.04
- Revenue Next Year
- COSM N/A
- LUMO N/A
- P/E Ratio
- COSM N/A
- LUMO N/A
- Revenue Growth
- COSM 15.73
- LUMO N/A
- 52 Week Low
- COSM $0.47
- LUMO $1.37
- 52 Week High
- COSM $2.05
- LUMO $4.55
- Technical
- Relative Strength Index (RSI)
- COSM 45.89
- LUMO 71.52
- Support Level
- COSM $1.07
- LUMO $3.38
- Resistance Level
- COSM $1.32
- LUMO $4.02
- Average True Range (ATR)
- COSM 0.15
- LUMO 0.37
- MACD
- COSM -0.01
- LUMO 0.01
- Stochastic Oscillator
- COSM 10.71
- LUMO 62.03
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.